Use of PD-L1 Biomarker in Second Line Therapy for Non-Small...

Value in Health 2018 / 05 Vol. 21

Use of PD-L1 Biomarker in Second Line Therapy for Non-Small Cell Lung Cancer: Budget Impact Analysis from a Private Payer Perspective In Brazil

Chabrol Haas, L, Coutinho, MB, Peixoto, RB, Ranieri, AS, Serra, FB
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.04.138
Date:
May, 2018
File:
PDF, 87 KB
english, 2018
Conversion to is in progress
Conversion to is failed